Sarepta Therapeutics, Inc.
The company discovers and develops RNA targeted therapeutics and gene therapies for the treatment of rare diseases. Through application of innovative technologies and collaborations with partners, the company develops and commercializes a treatment for Duchenne muscular dystrophy and develops potential treatments for limb-girdle muscular dystrophy and other neuromuscular and central nervous system-related disorders. Delaware-based
Overview
Overview | |
|---|---|
Country | United States |
State | Massachusetts |
Employees | 1314 |
Founded | 1980 |
Financials | |
|---|---|
Market Capitalization | 14.38B |
Revenue | 1.40B |
Operating Income | -94.83M |
Operating Margin | -6.76% |
Net Income | 16.90M |
Ranking
Operating Income
Operating Income Ranking | |
|---|---|
All | 4756 / 5373 |
Sector : Healthcare | 867 / 1144 |
Industry : Biotechnology | 438 / 645 |
Market Capitalization
Market Capitalization Ranking | |
|---|---|
All | 660 / 5565 |
Sector : Healthcare | 71 / 1182 |
Industry : Biotechnology | 11 / 670 |
Net Income
Net Income Ranking | |
|---|---|
All | 2275 / 5436 |
Sector : Healthcare | 159 / 1164 |
Industry : Biotechnology | 29 / 659 |
Employees
Employees Ranking | |
|---|---|
All | 2285 / 5330 |
Sector : Healthcare | 206 / 1174 |
Industry : Biotechnology | 17 / 667 |